Birch Hill Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$981K Buy
818
+140
+21% +$143K 0.04% 118
2026
Q1
$624K Buy
678
+64
+10% +$64.9K 0.03% 134
2025
Q4
$660K Buy
614
+39
+7% +$37.3K 0.03% 132
2025
Q3
$439K Sell
575
-25
-4% -$18.6K 0.02% 152
2025
Q2
$468K Buy
600
+341
+132% +$265K 0.02% 142
2025
Q1
$214K Buy
+259
New +$216K 0.01% 183
2024
Q2
Sell
-441
Closed -$343K 176
2024
Q1
$343K Buy
441
+2
+0.5% +$1.42K 0.02% 143
2023
Q4
$256K Hold
439
0.01% 144
2023
Q3
$236K Hold
439
0.01% 146
2023
Q2
$206K Buy
+439
New +$184K 0.01% 154

Other funds holding LLY

Birch Hill Investment Advisors's LLY Position: Q2 2026 in Review

Birch Hill Investment Advisors increased its Eli Lilly (LLY) stake by 21% in Q2 2026, buying an estimated $143K and bringing the position to 818 shares worth $981K. The position accounts for 0.04% of the portfolio, ranked #118.

Birch Hill Investment Advisors first reported a position in LLY in Q2 2023 and has held it in 10 quarters since. 1,754 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Birch Hill Investment Advisors held 818 shares of Eli Lilly worth $981K as of Q2 2026.
  • Birch Hill Investment Advisors bought 140 Eli Lilly shares in Q2 2026, an estimated $143K.
  • Eli Lilly made up 0.04% of Birch Hill Investment Advisors's portfolio in Q2 2026, its #118 holding.
  • Birch Hill Investment Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 10 quarters since.
  • 1,754 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Birch Hill Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.